Gladwin et al., 2009 - Google Patents
Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasisGladwin et al., 2009
- Document ID
- 8674186983818432833
- Author
- Gladwin M
- Kim-Shapiro D
- Publication year
- Publication venue
- Current opinion in hematology
External Links
Snippet
Storage lesion in banked blood due to hemolysis-dependent di... : Current Opinion in
Hematology Storage lesion in banked blood due to hemolysis-dependent disruption of nitric
oxide homeostasis : Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe …
- 238000003860 storage 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gladwin et al. | Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis | |
Helms et al. | Erythrocytes and vascular function: oxygen and nitric oxide | |
Kuhn et al. | Red blood cell function and dysfunction: redox regulation, nitric oxide metabolism, anemia | |
DeMartino et al. | Nitrite and nitrate chemical biology and signalling | |
Minneci et al. | Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin | |
Cabrales et al. | Blood substitutes: evolution from noncarrying to oxygen-and gas-carrying fluids | |
Alayash | Haptoglobin: old protein with new functions | |
Kosmachevskaya et al. | Alternate and additional functions of erythrocyte hemoglobin | |
Kanias et al. | Biopreservation of red blood cells–the struggle with hemoglobin oxidation | |
Yoshida et al. | Anaerobic storage of red blood cells | |
Kim-Shapiro et al. | Nitric oxide pathology and therapeutics in sickle cell disease | |
Vinchi et al. | Therapeutic approaches to limit hemolysis‐driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis | |
Gladwin | Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation | |
Yu et al. | Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice | |
Buehler et al. | Blood aging, safety, and transfusion: capturing the “radical” menace | |
WO1999001146A1 (en) | Treatment of hemoglobin containing erythrocytes with nitric oxide | |
AU2020267259B2 (en) | Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia | |
Kluger | Red cell substitutes from hemoglobin—do we start all over again? | |
Su et al. | The role of hemoglobin in nitric oxide transport in vascular system | |
Blood et al. | Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation | |
Muir et al. | Hemoglobin solutions and tissue oxygenation | |
Mozzarelli et al. | Chemistry and biochemistry of oxygen therapeutics: from transfusion to artificial blood | |
Cabrales | Examining and mitigating acellular hemoglobin vasoactivity | |
US20140017342A1 (en) | Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substitutes | |
Ortiz et al. | Transport of nitric oxide by perfluorocarbon emulsion |